[Ip-health] Senator Bernie Sanders Asks USTR to Endorse Waiver of WTO Patent Rules for Least Developed Countries

Peter Pitts ppitts at cmpi.org
Mon Sep 28 12:51:13 PDT 2015


Nope. 

How about "reality matters."

Peter J. Pitts

> On Sep 28, 2015, at 3:50 PM, Tahir Amin <tahir at i-mak.org> wrote:
> 
> Peter, 
> 
> Your comment could be intrepreted as #onlywhitelivesmatter?
> 
> Tahir
> 
>> On 28 September 2015 at 15:24, Jamie Love <james.love at keionline.org> wrote:
>> So Peter Pitts, as an expert on medicines, is it your opinion that the
>> people living in the poorest countries would not benefit from access to new
>> drugs, under patent, if they were available as affordable generic drugs?
>> And if so, how does that square with your consistent promotion of the
>> medical benefits of those same new drugs?
>> 
>> On Mon, Sep 28, 2015 at 3:19 PM, Peter Pitts <ppitts at cmpi.org> wrote:
>> 
>> > Weak end at Bernie’s
>> >
>> > Ahead of a Trans-Pacific Partnership (TPP) ministerial meeting later this
>> > week, a naïve attempt by the Senator from Ben & Jerry’s to generate some
>> > post-Papal ink …
>> >
>> > WASHINGTON, Sept. 28 – Sen. Bernie Sanders (I-Vt.) today asked the chief
>> > trade representative for the United States to ensure people in the poorest
>> > countries around the world have access to low-cost medicines.
>> >
>> > “Making sure people in poor countries have access to life-saving medicine
>> > is our moral responsibility,” Sen. Sanders wrote. “The European Commission
>> > and the Holy See both support a permanent exception for drug patents for
>> > these poor countries. The United States government should support this as
>> > well. Lives are at stake.”
>> >
>> > Bernie, FYI -- When you examine the WHO’s model Essential Drug List, very
>> > few of the 400 or so drugs deemed essential are new, or patented or were
>> > ever patented in the world’s poorest countries.  In category after
>> > category, from aspirin to Zithromax, in almost every case and in almost
>> > every country, these medicines have always been (or have been for many
>> > years) in the public domain.  That is, the medicine is fully open to legal
>> > and legitimate generic manufacture.
>> >
>> > As John Adams said, “Facts are pesky things.”
>> > _______________________________________________
>> > Ip-health mailing list
>> > Ip-health at lists.keionline.org
>> > http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
>> >
>> 
>> 
>> 
>> --
>> James Love.  Knowledge Ecology International
>> http://www.keionline.org/donate.html
>> KEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile:
>> +41.76.413.6584, twitter.com/jamie_love
>> _______________________________________________
>> Ip-health mailing list
>> Ip-health at lists.keionline.org
>> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
> 
> 
> 
> -- 
> Tahir Amin
> Co-Founder and Director of Intellectual Property
> Initiative for Medicines, Access & Knowledge (I-MAK)
> Website: www.i-mak.org
> Email: tahir at i-mak.org
> Skype: tahirmamin
> Tel: +1 917 455 6601/+44 771 853 9472
> 
> 
> 
> 



More information about the Ip-health mailing list